Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The safety of this combination during these periods has not been fully established
Among the mutations considered, Glu113Lys enhanced catalytic performance and was added to X(GD_L)dX(GD_L)f to yield X(GD_L)gX(GD_L)i
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with obesity or overweight and knee osteoarthritis, potential efficacy and tolerability of retatrutide, and the timeline for future readouts, presentations, and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
Negotiated prices take effect in 2026, and the list expands to 15 drugs in 2027 and 20 in 2028
This strategy not only reduces aggregation risk but also enhances ADC circulation half-life and therapeutic performance
F.GasbjergL
